These results align with observations from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) datasets (https://proteomics.cancer.gov/programs/cptac), which revealed notably different TMBIM1 protein levels between pancreatic tumors and normal tissues (Figure 1G). The gene discussed is TMBIM1; the disease is pancreatic neoplasm.